Form 8-K Vera Therapeutics, Inc. For: Jan 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Vera Therapeutics (VERA) Terminates ATM Offering
January 29, 2024 6:28 AM ESTEffective January 29, 2024, Vera Therapeutics Inc. (NASDAQ: VERA) suspended and terminated the prospectus (the ATM Prospectus) related to the sale of its Class A common stock, $0.001 par value per share (the Common Stock) in an at-the-market offering pursuant to the terms of the Sales Agreement, dated June 3, 2022, by and between the Company and Cowen and Company, LLC (the Sales Agreement). As a result, the Company will not make any sales of its Common... More



